Mihaylov S, Stark C, McColl E, Steen N, Vanoli A, Rubin G, Curless R, Barton R, Bond J
Clinical Trials Unit, Institute of Health and Society, Newcastle University, UK.
Health Technol Assess. 2008 May;12(13):iii-iv, ix-139. doi: 10.3310/hta12130.
To investigate the clinical effectiveness and cost-effectiveness of bulk-forming, stimulant and osmotic laxatives, and also of adding a second type of laxative agent in the treatment of patients whose constipation is not resolved by a single agent. Additionally, to define the meaning of constipation in older people from the perspective of GPs and older patients, and to investigate the use of prescribed and non-prescribed treatments for constipation in older people together with their adherence to prescribed treatments.
A multicentre pragmatic, factorial randomised controlled trial with economic evaluation and qualitative study using in-depth interviews and focus groups with older people, GPs and community nurses.
General practices in north-east England.
People aged 55 years or over with chronic constipation living in private households.
Six stepped-treatment strategies using three classes of laxatives: bulk, stimulant and osmotic preparations, singly and in combination.
The primary outcome was the constipation-specific Patient Assessment of Constipation--Symptoms/Patient Assessment of Constipation--Quality of Life. Secondary outcomes included EuroQoL 5 Dimensions, reported number of bowel movements per week, the presence/absence of the other Rome II criteria for constipation, adverse effects of treatment and relapse rates.
Recruitment to the trial was difficult and the trial was closed after recruiting 19 participants. GP participants provided patient-centred definitions that focused on the idea of a change from the norm as defined by the individual patient and 'textbook definitions' that focused on reduced frequency of defecation associated with a range of unpleasant sensations and other clinical symptoms. Nurses' definitions of constipation included both a patient-centred perspective and the description of particular symptoms associated with constipation. Older participants defined constipation in terms of frequency of bowel movements and changes in normal bowel routine. Older participants perceived constipation as follows: linked to specific diseases, medical conditions or health problems; caused by the consumption of specific medications or surgical procedures; caused by diet or eating habits; part of the ageing process; due to not going to the toilet when having the urge to defecate; hereditary; caused by stress or worry; and caused by environmental exposure. GP participants suggested that constipation is due to changes in diet and lifestyle; the physiology and degenerative processes of ageing; and the iatrogenic impact of opiate medications. Nurse participants identified that constipation is linked to decreased mobility, decreased food intake, decreased fluid intake and consumption of certain medications. For many older people their constipation emerged as a problem over a period of time; for some the 'condition' had existed for many years. Self-management of constipation had typically been their first response to the symptoms and continued once professional help had been sought. Older participants had a wide experience of different management strategies and treatments for constipation, and at the time of the study had firm preferences about the laxatives they would use. GP participants recognised the experience and use of laxatives of their patients. They exhibited strong personal preferences for different laxatives, often prescribing them in combination. Nurses were more likely than GPs to treat and prevent constipation using non-laxative measures; these included providing advice on appropriate dietary changes, increasing fluid intake and, if possible, encouraging exercise and mobility.
There is little shared understanding between patients and professionals about 'normal' bowel function with little consensus in general practice of the optimum management strategies for chronic constipation and the most effective strategies to use. Chronic constipation is seen as less important than other conditions prevalent in general practice (e.g. diabetes) because it is not an agreed management target within national frameworks. Consequently, practitioners had little interest in constipation as a research topic. Patient preferences and the absence of patient equipoise formed an enormous barrier to the recruitment of patients in the implementation of this trial. Studies are needed to investigate different methods of recruitment within the constraints of current ethical guidelines on 'opting in' and to identify barriers and facilitators to recruitment to complex trials in general. Patient preference trials and natural cohort observational studies are also needed to investigate the effectiveness or cost-effectiveness of different laxatives and treatment strategies in the management of chronic constipation.
研究容积性、刺激性和渗透性泻药的临床疗效及成本效益,以及在单一药物治疗无效的便秘患者中加用第二种泻药的效果。此外,从全科医生(GP)和老年患者的角度定义老年人便秘的含义,并调查老年人便秘的处方药和非处方药治疗的使用情况及其对规定治疗的依从性。
一项多中心实用、析因随机对照试验,包括经济评估以及使用对老年人、全科医生和社区护士进行深入访谈和焦点小组讨论的定性研究。
英格兰东北部的全科诊所。
年龄在55岁及以上、居住在私人家庭且患有慢性便秘的人群。
采用三类泻药(容积性、刺激性和渗透性制剂)的六种阶梯治疗策略,单独使用或联合使用。
主要结局是便秘特异性的便秘患者症状评估/便秘患者生活质量评估。次要结局包括欧洲五维健康量表、每周报告的排便次数、是否存在便秘的其他罗马II标准、治疗的不良反应和复发率。
试验招募困难,招募19名参与者后试验结束。全科医生参与者提供了以患者为中心的定义,重点是个体患者定义的与正常情况的变化,以及侧重于排便频率降低并伴有一系列不适感觉和其他临床症状的“教科书定义”。护士对便秘的定义包括以患者为中心的观点以及与便秘相关的特定症状的描述。老年参与者根据排便频率和正常排便习惯的变化来定义便秘。老年参与者对便秘的认知如下:与特定疾病、医疗状况或健康问题有关;由特定药物的使用或外科手术引起;由饮食或饮食习惯引起;衰老过程的一部分;因有便意时未上厕所所致;遗传性;由压力或担忧引起;以及由环境暴露引起。全科医生参与者认为便秘是由于饮食和生活方式的改变、衰老的生理和退行性过程以及阿片类药物的医源性影响。护士参与者指出便秘与活动能力下降、食物摄入量减少、液体摄入量减少以及某些药物的使用有关。对许多老年人来说,他们的便秘是在一段时间内出现的问题;对一些人来说,这种“状况”已经存在多年。便秘的自我管理通常是他们对症状的第一反应,并且在寻求专业帮助后仍会继续。老年参与者对便秘有广泛的不同管理策略和治疗经验,在研究时对他们会使用的泻药有明确的偏好。全科医生参与者认可他们患者使用泻药的经验。他们对不同的泻药表现出强烈的个人偏好,经常联合开处方。与全科医生相比,护士更有可能使用非泻药措施治疗和预防便秘;这些措施包括就适当的饮食改变提供建议、增加液体摄入量,以及在可能的情况下鼓励运动和活动。
患者和专业人员对“正常”肠道功能的理解几乎没有共识,在慢性便秘的最佳管理策略和最有效使用策略的全科医疗实践中也几乎没有达成共识。慢性便秘被认为不如全科医疗中普遍存在的其他疾病(如糖尿病)重要,因为它不是国家框架内商定的管理目标。因此,从业者对便秘作为一个研究主题兴趣不大。患者的偏好以及缺乏患者平衡在该试验实施中对患者招募构成了巨大障碍。需要开展研究以在当前关于“选择加入”的伦理准则限制内调查不同的招募方法,并确定一般复杂试验招募的障碍和促进因素。还需要进行患者偏好试验和自然队列观察性研究,以调查不同泻药和治疗策略在慢性便秘管理中的有效性或成本效益。